XML 12 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Statements of Convertible Preferred Stock and Stockholders' Equity/(Deficit) - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Common Stock
Additional paid-in-capital
Accumulated other comprehensive income/ (loss)
Accumulated deficit
Beginning balance, convertible preferred stock, (in shares) at Dec. 31, 2022   144,589,706        
Beginning balance, convertible preferred stock at Dec. 31, 2022   $ 147,946        
Beginning balance, (in shares) at Dec. 31, 2022     1,167,240      
Beginning balance at Dec. 31, 2022 $ (81,696)     $ 5,377 $ (398) $ (86,675)
Vesting of early exercised stock options, (in shares)     17,505      
Vesting of early exercised stock options, value 52     52    
Exercise of stock options Value 31     31    
Exercise of stock options (in shares)     9,195      
Stock-based compensation 615     615    
Unrealized gain (loss) on short-term investments 278       278  
Net loss (11,719)         (11,719)
Ending balance, (in shares) at Mar. 31, 2023     1,193,940      
Ending balance at Mar. 31, 2023 (92,439)     6,075 (120) (98,394)
Ending balance, convertible preferred stock, (in shares) at Mar. 31, 2023   144,589,706        
Ending balance, convertible preferred stock at Mar. 31, 2023   $ 147,946        
Issuance of Series C convertible preferred stock, net of $329 in issuance costs (in shares)   142,857,138        
Issuance of Series C convertible preferred stock, net of $329 in issuance costs   $ 99,671        
Vesting of early exercised stock options, (in shares)     12,164      
Vesting of early exercised stock options, value 36     36    
Exercise of stock options Value 26     26    
Exercise of stock options (in shares)     7,209      
Stock-based compensation 927     927    
Unrealized gain (loss) on short-term investments (20)       (20)  
Net loss (12,398)         (12,398)
Ending balance, (in shares) at Jun. 30, 2023     1,213,313      
Ending balance at Jun. 30, 2023 $ (103,868)     7,064 (140) (110,792)
Ending balance, convertible preferred stock, (in shares) at Jun. 30, 2023   287,446,844        
Ending balance, convertible preferred stock at Jun. 30, 2023   $ 247,617        
Beginning balance, convertible preferred stock, (in shares) at Dec. 31, 2023 287,446,844 287,446,844        
Beginning balance, convertible preferred stock at Dec. 31, 2023 $ 247,617 $ 247,617        
Beginning balance, (in shares) at Dec. 31, 2023     1,247,012      
Beginning balance at Dec. 31, 2023 (127,082)     8,987 40 (136,109)
Vesting of early exercised stock options, (in shares)     522      
Vesting of early exercised stock options, value 2     2    
Exercise of stock options Value 59     59    
Exercise of stock options (in shares)     15,104      
Stock-based compensation 1,328     1,328    
Unrealized gain (loss) on short-term investments (61)       (61)  
Net loss (15,430)         (15,430)
Ending balance, (in shares) at Mar. 31, 2024     1,262,638      
Ending balance at Mar. 31, 2024 $ (141,184)     10,376 (21) (151,539)
Ending balance, convertible preferred stock, (in shares) at Mar. 31, 2024   287,446,844        
Ending balance, convertible preferred stock at Mar. 31, 2024   $ 247,617        
Beginning balance, convertible preferred stock, (in shares) at Dec. 31, 2023 287,446,844 287,446,844        
Beginning balance, convertible preferred stock at Dec. 31, 2023 $ 247,617 $ 247,617        
Beginning balance, (in shares) at Dec. 31, 2023     1,247,012      
Beginning balance at Dec. 31, 2023 $ (127,082)     8,987 40 (136,109)
Exercise of stock options (in shares) 15,211          
Ending balance, (in shares) at Jun. 30, 2024     22,254,102      
Ending balance at Jun. 30, 2024 $ 179,246   $ 2 347,823 (64) (168,515)
Ending balance, convertible preferred stock, (in shares) at Jun. 30, 2024 0          
Ending balance, convertible preferred stock at Jun. 30, 2024 $ 0          
Beginning balance, convertible preferred stock, (in shares) at Mar. 31, 2024   287,446,844        
Beginning balance, convertible preferred stock at Mar. 31, 2024   $ 247,617        
Beginning balance, (in shares) at Mar. 31, 2024     1,262,638      
Beginning balance at Mar. 31, 2024 (141,184)     10,376 (21) (151,539)
Conversion of convertible preferred stock into common stock upon initial public offering, (in shares)   (287,446,844)        
Conversion of convertible preferred stock into common stock upon initial public offering, value   $ (247,617)        
Issuance of common stock in initial public offering, net of $12,305 in discounts and offering costs, (in shares)     6,250,000      
Issuance of common stock in initial public offering, net of $12,305 in discounts and offering costs, value 87,695   $ 1 87,694    
Conversion of convertible preferred stock into common stock upon initial public offering, (in shares)     14,740,840      
Conversion of convertible preferred stock into common stock upon initial public offering, value 247,617   $ 1 247,616    
Vesting of early exercised stock options, (in shares)     524      
Vesting of early exercised stock options, value 2     2    
Exercise of stock options (in shares)     100      
Stock-based compensation 2,135     2,135    
Unrealized gain (loss) on short-term investments (43)       (43)  
Net loss (16,976)         (16,976)
Ending balance, (in shares) at Jun. 30, 2024     22,254,102      
Ending balance at Jun. 30, 2024 $ 179,246   $ 2 $ 347,823 $ (64) $ (168,515)
Ending balance, convertible preferred stock, (in shares) at Jun. 30, 2024 0          
Ending balance, convertible preferred stock at Jun. 30, 2024 $ 0